Adult and Adolescent Vaccines Market to 2018 – Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 8
1.2 List of Figures 12
2 Adult and Adolescent Vaccines Market to 2018 – Introduction 14
2.1 Overview 14
3 Adult and Adolescent Vaccines Market to 2018 – Overview 15
3.1 Vaccine Preventable Diseases 15
3.1.1 Types of Vaccines 16
3.2 Recommendations for Immunization 17
3.2.1 The US 17
3.2.2 Top Five European Countries 19
3.2.3 Japan 20
3.3 Regulatory Framework 21
3.3.1 The US 21
3.3.2 Top Five European Countries 22
3.3.3 Japan 23
3.4 Vaccine Manufacturing Process 24
4 Adult and Adolescent Vaccines Market to 2018 – Market Characterization and Forecast 25
4.1 Revenue Forecast 25
4.2 Market Share by Type of Vaccines 27
4.3 Market Share by Geography 28
4.4 Drivers 28
4.4.1 Adult Vaccines Segment to Drive Future Growth 28
4.4.2 High Unmet Needs 28
4.4.3 Targeting New Diseases Areas for Vaccines Likely To Drive the Market 29
4.4.4 Novel Vaccine Technologies 29
4.5 Restraints 30
4.5.1 Production Capacity Limitations 30
4.5.2 High Initial Capital Investments and Technical Expertise 30
4.5.3 Regulations Delay Vaccine Launch and Acceptance 30
5 Adult and Adolescent Vaccines Market to 2018 – Influenza Vaccines 31
5.1 Disease Overview 31
5.2 Market Forecasts 32
5.2.1 The US 32
5.2.2 Top Five European Countries 34
5.2.3 Japan 36
5.3 Cost of Vaccination 37
5.3.1 The US 37
5.3.2 Top Five European Countries 37
5.3.3 Japan 38
5.4 Pipeline Analysis – Influenza Vaccines 39
6 Adult and Adolescent Vaccines Market to 2018 – Tetanus, Diphtheria and Pertussis Vaccines 42
6.1 Disease Overview 42
6.2 Market Forecasts 43
6.2.1 The US 43
6.2.2 Top Five European Countries 44
6.2.3 Japan 46
6.3 Cost of Vaccination 47
6.3.1 The US 47
6.3.2 Top Five European Countries 47
6.3.3 Japan 48
6.4 Pipeline Analysis – Tetanus, Diphtheria, Pertussis (Td/Tdap) Vaccines 49
7 Adult and Adolescent Vaccines Market to 2018 – Pneumococcal Vaccines 50
7.1 Disease Overview 50
7.2 Market Forecasts 51
7.2.1 The US 51
7.2.2 Top Five European Countries 53
7.2.3 Japan 55
7.3 Cost of Vaccination 56
7.3.1 The US 56
7.3.2 Top Five European Countries 56
7.3.3 Japan 57
7.4 Pipeline Analysis – Pneumococcal Vaccines 58
8 Adult and Adolescent Vaccines Market to 2018 – Meningococcal Vaccines 60
8.1 Disease Overview 60
8.2 Market Forecasts 61
8.2.1 The US 61
8.2.2 Top Five European Countries 62
8.3 Cost of Vaccination 64
8.3.1 The US 64
8.3.2 Top Five European Countries 64
8.4 Pipeline Analysis – Meningococcal Vaccines 65
9 Adult and Adolescent Vaccines Market to 2018 – Human Papilloma Virus Vaccines 66
9.1 Disease Overview 66
9.2 Market Forecasts 67
9.2.1 The US 67
9.2.2 Top Five European Countries 68
9.2.3 Japan 70
9.3 Cost of Vaccination 71
9.3.1 The US 71
9.3.2 Top Five European Countries 71
9.3.3 Japan 72
9.4 Pipeline Analysis – Human Papillomavirus Vaccines 73
10 Adult and Adolescent Vaccines Market to 2018 – Hepatitis Vaccines 75
10.1 Disease Overview 75
10.2 Market Forecasts 76
10.2.1 The US 76
10.2.2 Top Five European Countries 77
10.2.3 Japan 79
10.3 Cost of Vaccination 80
10.3.1 The US 80
10.3.2 Top Five European Countries 80
10.3.3 Japan 81
10.4 Pipeline Analysis – Hepatitis Vaccines 82
11 Adult and Adolescent Vaccines Market to 2018 – Measles, Mumps and Rubella Vaccines 85
11.1 Disease Overview 85
11.2 Market Forecasts 85
11.2.1 The US 85
11.2.2 Top Five European Countries 87
11.3 Cost of Vaccination 88
11.3.1 The US 88
11.3.2 Top Five European Countries 89
12 Adult and Adolescent Vaccines Market to 2018 – Zoster Vaccines 90
12.1 Disease Overview 90
12.2 Market Forecasts 90
12.2.1 The US 90
12.2.2 The UK 91
12.3 Cost of Vaccination 91
12.3.1 The US 91
12.3.2 The UK 92
12.4 Pipeline Analysis – Zoster Vaccines 92
13 Adult and Adolescent Vaccines Market to 2018 – Varicella Vaccines 93
13.1 Disease Overview 93
13.2 Market Forecasts 93
13.2.1 The US 93
13.2.2 Top Five European Countries 94
13.2.3 Japan 96
13.3 Cost of Vaccination 97
13.3.1 The US 97
13.3.2 Top Five European Countries 97
13.3.3 Japan 98
13.4 Pipeline Analysis – Varicella Vaccines 98
14 Adult and Adolescent Vaccines Market to 2018 – Competitive Landscape 99
14.1 Introduction 99
14.2 Major Company Profiles 99
14.2.1 GlaxoSmithKline 99
14.2.2 Sanofi 101
14.2.3 Pfizer 102
14.2.4 Merck 103
14.2.5 Novartis 104
15 Adult and Adolescent Vaccines Market to 2018 – Strategic Consolidations 105
15.1 Deals by Year 105
15.2 Deals by Type 106
15.3 Deals by Value 107
15.4 Deals by Geography 108
15.5 Summary of Major M&A Deals 109
15.6 Summary of Major Licensing Deals 110
15.7 Summary of Major Partnerships 111
16 Adult and Adolescent Vaccines Market to 2018 – Appendix 113
16.1 Market Definitions 113
16.2 Abbreviations 113
16.3 Bibliography 115
16.4 Research Methodology 115
16.4.1 Coverage 115
16.4.2 Secondary Research 116
16.4.3 Primary Research 116
16.4.4 Model for Estimation of Vaccine Market 117
16.5 Geographical Landscape 119
16.6 Pipeline Analysis 119
16.7 Competitive Landscape 119
16.7.1 Expert Panel Validation 119
16.8 Contact Us 119
16.9 Disclaimer 119